Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

‘Population autopsy’ finds the US with more avoidable deaths than other wealthy countries
The United States appears to be leading all high-income countries in an unfortunate, distinctly undesirable statistical category.
Bayer's new imaging agent for cardiac amyloidosis impresses in clinical trial
The REVEAL study has been assessing the sensitivity and specificity of iodine 124 evuzamitide (I 124 evuzamitide), a PET agent capable of visualizing signs of cardiac amyloidosis on imaging.
AATS helps heart surgeons diagnose and manage heparin-induced thrombocytopenia
Heparin-induced thrombocytopenia after heart surgery is a major concern, but prior guidelines were developed without much feedback from actual cardiac surgeons.
FDA announces more recalls due to risk of syringe breaking during treatment
Medline already had to recall millions of syringes due to a significant safety risk. Now, multiple procedure kits that include the devices are also being recalled. The issue has been associated with four serious injuries.
How expert guidelines have influenced TAVR vs. SAVR decisions
As popular as TAVR is today, SAVR continues to play a significant role in the management of patients with valvular disease.

‘Population autopsy’ finds the US with more avoidable deaths than other wealthy countries

The United States appears to be leading all high-income countries in an unfortunate, distinctly undesirable statistical category.

A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]

Bayer's new imaging agent for cardiac amyloidosis impresses in clinical trial

The REVEAL study has been assessing the sensitivity and specificity of iodine 124 evuzamitide (I 124 evuzamitide), a PET agent capable of visualizing signs of cardiac amyloidosis on imaging.

Subhasis Chatterjee, MD. FACS, FACC, FCCP, Associate Professor of Surgery, Director Thoracic Surgical ICU and ECMO Program, Texas Heart Institute at CHI Baylor St. Lukes, explains the new 2026 expert consensus on heparin induced thrombocytopenia (HIT) released at the American Association for Thoracic Surgery (AATS) 2026 annual meeting. #AATS #AATS2026 #AATS26

AATS helps heart surgeons diagnose and manage heparin-induced thrombocytopenia

Heparin-induced thrombocytopenia after heart surgery is a major concern, but prior guidelines were developed without much feedback from actual cardiac surgeons.

doctor wrong patient wrong-site surgery medical error malpractice mistake

FDA announces more recalls due to risk of syringe breaking during treatment

Medline already had to recall millions of syringes due to a significant safety risk. Now, multiple procedure kits that include the devices are also being recalled. The issue has been associated with four serious injuries.

How expert guidelines have influenced TAVR vs. SAVR decisions

As popular as TAVR is today, SAVR continues to play a significant role in the management of patients with valvular disease.

Medical malpractice gavel diagnostic error mistake stethoscope

Iowa hospital sued after allegedly extracting patient’s organs without family consent

In a lawsuit, the daughters of a deceased patient accuse Alegent Health-Community Memorial Hospital of Missouri Valley of medical malpractice and negligence, alleging donations were harvested without proper consultation. It’s alleged that their father was not registered as an organ donor.

Video of Makoto Hashimoto, MD, PhD, professor and director of robotic cardiac surgery at Florida International University, Baptist Health, who presented a study on robotic surgery outcomes and costs at the American Association for Thoracic Surgery (AATS) 2026 annual meeting this week. While the costs of these minimally invasive robotic procedures is higher that traditional surgical procedures, he said costs overall can be reduced in terms of faster patient recovery, shorter length of stays.

Upfront costs of robotic heart surgery are high—but it may be a smart investment

Makoto Hashimoto, MD, PhD, said robotic procedures are associated with a faster recovery time and many other potential benefits.

Physician and his practice to pay $6.7M for allegedly performing unnecessary vascular procedures

The physician was accused of pressuring Medicare patients into undergoing treatment they did not need. One patient allegedly received 42 different stents over an eight-year period.